Advertisement

The Influence of Steroid Hormones and Antihormones on the Growth and Differentiation of Normal Human Breast Cells in Culture

  • Frederique Kuttenn
  • Anne Gompel
  • Catherine Malet
  • Etienne Leygue
  • Nicole Baudot
  • Geneviere Plu
  • Jean-Christophe Thalabard
  • Pierre Mauvais-Jarvis

Abstract

Breast cancer still remains the most frequent cancer in women, occurring in 1 out of 9 women, whereas advances in therapeutics have not led to a decrease in mortality. Only a policy of early screening in high-risk populations and of prevention based on a clear pathophysiological understanding could lead to a decrease in the mortality due to this cancer.

Keywords

Breast Cancer Benign Breast Disease Human Breast Epithelial Cell Normal Human Breast Estradiol Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Prudhomme JF, Malet C, Gompel A, Lalardrie JP, Ochoa C, Boue A, Mauvais-Jarvis P, Kuttenn F (1984) l7ß-hydroxysteroid dehydrogenase activity in human breast epithelial cell and fibroblast cultures. Endocrinology 114: 1483–1489.Google Scholar
  2. 2.
    Chomette G, Gompel A, Malet C, Tranbaloc P, Kuttenn F, Mauvais-Jarvis P (1985) Les cellules épithéliales du sein humain normal en culture. Aspects ultrastructuraux et leurs variations sous l’effet d’actions hormonales (estradiol, prolactine). Arch Anat Cytol Path 33: 32–38.Google Scholar
  3. 3.
    Gompel A, Chomette G, Malet C, Spritzer P, Pavy B, Kuttenn F, Mauvais-Jarvis P (1985) Estradiol-progestin interaction in normal human breast cells in culture. Ultrastructural studies. Breast Diseases 1: 149–156.Google Scholar
  4. 4.
    Chomette G, Auriol M, Tranbaloc P, Gompel A, Malet C., Kuttenn F (1986) Effect of estradiol and the synthetic progestin promegestone (R5020) on human breast cell cultures. An ultrastructural study. Path Res Pract 181: 273–279.Google Scholar
  5. 5.
    Malet C, Gompel A, Spritzer P, Kuttenn F, Mauvais-Jarvis P (1986) Effect of estradiol and the synthetic progestin promegestone (R5020) on the proliferation of human epithelial mammary cells in culture. In: Endocrinology of the Breast. Basic and Clinical Aspects. Ann N.Y. Acad Sci 464: 489–492.Google Scholar
  6. 6.
    Gompel A, Malet C, Spritzer P, Lalardrle JP, Kuttenn F, Mauvais-Jarvis P (1986) Progestin effect on cell proliferation and 17ß-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J Clin Endocrinol Metab 63: 1174–1180.PubMedCrossRefGoogle Scholar
  7. 7.
    Barrat J, Lignieres B de, Marpeau L, Larue L, Fournier S, Nahoul K, Linares G, Giorgi H, Contesso G (1990) Effet in vivo de l’administration locale de progesterone sur l’activité mitotique des galactophores humans J Gynecol Obstet Biol Reprod 19: 269–274.Google Scholar
  8. 8.
    Tseng L, Gusberg SB, Gurpide E (1977) Estradiol receptor and 17ßdehydrogenase in normal and abnormal human endometrium. Ann NY Acad Sci 286: 190–198.PubMedCrossRefGoogle Scholar
  9. 9.
    Fournier S, Kuttenn F, Cicco N de, Baudot N, Malet C, Mauvais-Jarvis P (1982) Estradiol 17f3-hydroxysteroid dehydrogenase activity in human breast fibroadenomas. J Clin Endocrinol Metab 55: 428–433.PubMedCrossRefGoogle Scholar
  10. 10.
    Kuttenn F, Fournier S, Durand JC, Mauvais-Jarvis P (1981) Estradiol and progesterone receptors in human breast fibroadenomas. J Clin Endocrinol Metab 52: 1225–1229.PubMedCrossRefGoogle Scholar
  11. 11.
    Malet C, Gompel A, Pritzer P, Bricout N, Yaneva H, Mowszowicz I, Kuttenn F, Mauvais-Jarvis P (1988) Tamoxifen and hydroxytamoxifen isomers vs. estradiol effects on normal human breast cells in culture. Cancer Res 48: 7193–7199.PubMedGoogle Scholar
  12. 11.
    Malet C, Gompel A, Pritzer P, Bricout N, Yaneva H, Mowszowicz I, Kuttenn F, Mauvais-Jarvis P (1988) Tamoxifen and hydroxytamoxifen isomers vs. estradiol effects on normal human breast cells in culture. Cancer Res 48: 7193–7199.PubMedGoogle Scholar
  13. 13.
    Dubik D, Dembinski TC, Shiu RP (1987) Stimulation of c-myc oncogene expression associated with estrogen proliferation of human breast cancer cells. Cancer Res 47: 6517–6521.PubMedGoogle Scholar
  14. 14.
    Dubik D, Shiu RPC (1988) Transcriptional regulation of c-myc oncogene expression by estrogen in hormone responsive human breast cancer cells. J Biol Chem 263: 12705–12708.PubMedGoogle Scholar
  15. 15.
    Santos GF, Scott GK, Lee WMF, Liu E, Benz C (1988) Estrogen-induced post-transcriptional modulation of c-myc protooncogene expression in human breast cancer cells. J Biol Chem 263: 9565–9568.PubMedGoogle Scholar
  16. 16.
    Lippman ME, Dickson RB (1989) Mechanisms of growth control in normal and malignant breast epithelium. Rec Prog Horm Res 45: 383–435.PubMedGoogle Scholar
  17. 17.
    Studzinsky GP, Brelvi ZS, Feldman SC, Watt RA (1986) Participation of cmyc protein in DNA synthesis of human cells. Science 234: 467–470.CrossRefGoogle Scholar
  18. 18.
    Murphy LJ, Murphy LC, Friesen HG (1987) Estrogen induction of N-myc and c-myc protooncogene expression in rat uterus. Endocrinology 120: 1882–1888.CrossRefGoogle Scholar
  19. 19.
    Weisz A, Bresciani F (1988) Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Mol Endocrinol 2: 816–824.PubMedCrossRefGoogle Scholar
  20. 20.
    Odom LD, Barrett JM, Pantazis CG, Stoddard LD, Mc Donough PG (1989) Immunocytochemical study of ras and myc protooncogene polypeptide expression in the human menstrual cycle. Am J Obstet Gynecol 161: 1663–1668.CrossRefGoogle Scholar
  21. 21.
    Fink KL, Wieben ED, Woloschak GE, Spelberg TC (1988) Rapid regulation of c-myc protooncogene expression by progesterone in the avian oviduct. Proc Natl Acad Sci 85: 1796–1800.PubMedCrossRefGoogle Scholar
  22. 22.
    Gompel A, Leygue E, Gol R, Malet C, Baudot N, Mowszowicz I, Kuttenn F, Mauvais-Jarvis P (1991) Estradiol and antiestrogen interactions with cmyc expresssion in normal human breast epithelial (HBE) cells. 73th Ann Meet Am Endoc Soc, Washington, Abstract 595.Google Scholar
  23. 23.
    Moolgavkar SH, Day NE, Stevens RC (1980) Two-stage model for carcinogenesis: epidemiology of breast cancer in females. J Natl Cancer Inst 45: 559–569.Google Scholar
  24. 24.
    Pike M, Henderson B, Krailo M et al (1983) Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet iî: 926–930.Google Scholar
  25. 25.
    Bergkvist L, Adami M, Persson I, Hoover R, Schairer C (1989) The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321: 293–297.PubMedCrossRefGoogle Scholar
  26. 26.
    Lerner LF, Jordon VC (1990) Development of antiestrogens and their use in breast cancer: Eight Cain Memorial Award Lecture. Cancer Res 50: 41774189.Google Scholar
  27. 27.
    Bardon S, Vignon F, Derocq D, Rochefort H (1984) The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor. Moll Cell Endocrinol 35: 89–96.CrossRefGoogle Scholar
  28. 28.
    Cuzick J, Wang DY, Bulbrook RD (1986) The prevention of breast cancer. Lancet i: 83–86.Google Scholar
  29. 29.
    Fentiman IS (1989) The endocrine prevention of breast cancer. Br J Cancer 60: 12–14.PubMedCrossRefGoogle Scholar
  30. 30.
    Powles TJ, Hardy JR, Ashley SE, Farrington GM, Cosgrove D, Davey JB, Dowsett M, Mc Kinna JA, Nash AG, Sinnett HD, Tyllier CR, Treleaven JG (1989) A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer 60: 126–131.PubMedCrossRefGoogle Scholar
  31. 31.
    Love RR (1990) Prospects for antiestrogen chemoprevention of breast cancer. J Natl Cancer Inst 82: 18–21.PubMedCrossRefGoogle Scholar
  32. 32.
    Eckert RL, Katzenellenbogen BS (1982) Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells. Cancer Res 42: 139–144.PubMedGoogle Scholar
  33. 33.
    Katzenellenbogen BS, Norman MJ, Eckert RL, Peltz SW, Mangel WF (1984) Bioactivities, estrogen receptor interactions and plasminogen activator-inducing activities of tamoxifen and hydroxytamoxifen isomers in MCF-7 human breast cancer cells. Cancer Res 35: 89–96.Google Scholar
  34. 34.
    Sherman BM, Chapler FK, Crickard K, Wycoff D (1979) Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women. J Clin Invest 64: 398–494.PubMedCrossRefGoogle Scholar
  35. 35.
    Fornander T, Cedermark B, Mattsson A et al. (1989) Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet i, 117119.Google Scholar
  36. 36.
    Mauvais-Jarvis P, Baudot N, Castaigne D, Banzet P, Kuttenn F (1986) Trans-4-hydroxytamoxifen concentration and metabolism after local percutaneous administration to human breast. Cancer Res 46: 1521–1525.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1992

Authors and Affiliations

  • Frederique Kuttenn
  • Anne Gompel
  • Catherine Malet
  • Etienne Leygue
  • Nicole Baudot
  • Geneviere Plu
  • Jean-Christophe Thalabard
  • Pierre Mauvais-Jarvis

There are no affiliations available

Personalised recommendations